Gregor K Wenning Selected Research

Dementia (Dementias)

10/2020	Has Deep Brain Stimulation Changed the Very Long-Term Outcome of Parkinson's Disease? A Controlled Longitudinal Study.
1/2017	Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy.
1/2016	Glia and alpha-synuclein in neurodegeneration: A complex interaction.
6/2011	Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregor K Wenning Research Topics

Disease

70	Multiple System Atrophy 01/2022 - 08/2003
42	Parkinson Disease (Parkinson's Disease) 05/2024 - 08/2003
23	Parkinsonian Disorders (Parkinsonism) 10/2023 - 05/2003
23	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021 - 08/2003
15	Synucleinopathies 01/2022 - 09/2009
12	Cerebellar Ataxia (Dysmetria) 01/2022 - 09/2003
8	Disease Progression 11/2023 - 09/2003
7	Neuroinflammatory Diseases 01/2023 - 11/2007
6	Orthostatic Hypotension (Postural Hypotension) 01/2020 - 02/2015
6	Striatonigral Degeneration 10/2015 - 08/2003
5	Gliosis 01/2020 - 08/2005
4	Olivopontocerebellar Atrophies (Olivopontocerebellar Atrophy) 11/2021 - 03/2005
4	Movement Disorders (Movement Disorder) 04/2021 - 03/2004
4	Dementia (Dementias) 10/2020 - 06/2011
3	Hypertension (High Blood Pressure) 04/2024 - 01/2019
3	Autonomic Nervous System Diseases (Dysautonomia) 03/2023 - 03/2005
3	Psychotic Disorders (Schizoaffective Disorder) 10/2020 - 03/2004
3	Dystonia (Limb Dystonia) 01/2020 - 08/2007
3	Shy-Drager Syndrome 01/2013 - 08/2010
3	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2012 - 08/2006
3	Huntington Disease (Huntington's Disease) 03/2006 - 05/2002
2	Dizziness (Lightheadedness) 01/2020 - 02/2015
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2019
2	Proteostasis Deficiencies 01/2019 - 01/2016
2	Torticollis (Wryneck) 08/2007 - 01/2002
2	Dystonic Disorders (Writer's Cramp) 08/2007 - 12/2005
1	Pure Autonomic Failure 02/2024
1	Cerebellar Diseases (Cerebellar Syndrome) 10/2023
1	Infections 03/2023
1	COVID-19 03/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 09/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Inflammation (Inflammations) 01/2020
1	Multiple Sclerosis 01/2020
1	Syncope (Fainting) 01/2020
1	Cognitive Dysfunction 01/2020
1	Dyspnea (Shortness of Breath) 01/2020
1	Fatigue 01/2020
1	Lewy Body Disease (Lewy Body Dementia) 01/2020
1	Hypovolemia 01/2020
1	Low Back Pain (Lumbago) 01/2020
1	Pain (Aches) 01/2020
1	Hypertensive Crisis 01/2020
1	Respiratory Sounds (Crackle) 10/2019
1	Iron Overload 01/2019
1	Prodromal Symptoms 01/2019
1	Atrophy 01/2018

Drug/Important Bio-Agent (IBA)

35	SynucleinsIBA 02/2024 - 02/2011
15	Levodopa (L Dopa)FDA LinkGeneric 10/2023 - 09/2003
13	alpha-SynucleinIBA 01/2017 - 08/2003
11	Biomarkers (Surrogate Marker)IBA 11/2023 - 05/2003
6	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 05/2017 - 07/2005
5	IronIBA 01/2023 - 10/2005
5	CytokinesIBA 01/2020 - 08/2003
4	rasagiline (Azilect)FDA Link 01/2022 - 04/2008
4	serum P-component (CIt)IBA 05/2017 - 04/2011
4	3-nitropropionic acidIBA 05/2012 - 08/2003
4	Riluzole FDA LinkGeneric 01/2006 - 01/2002
3	Antihypertensive Agents (Antihypertensives)IBA 04/2024 - 04/2016
3	PrionsIBA 09/2021 - 10/2006
3	hydroxide ionIBA 01/2020 - 03/2016
3	Proteins (Proteins, Gene)FDA Link 08/2015 - 08/2003
3	Amantadine (Aman)FDA LinkGeneric 01/2006 - 03/2004
2	Toll-Like Receptor 4IBA 10/2021 - 01/2017
2	Dronabinol (THC)FDA LinkGeneric 10/2020 - 01/2020
2	3- (1,3- benzodioxol- 5- yl)- 5- (3- bromophenyl)- 1H- pyrazoleIBA 01/2019 - 01/2016
2	Peroxidase (Myeloperoxidase)IBA 10/2015 - 05/2012
2	Botulinum Toxins (Botulinum Toxin)IBA 08/2007 - 12/2005
2	Dopamine (Intropin)FDA LinkGeneric 09/2006 - 02/2005
2	2beta- carbomethoxy- 3beta- (4- iodophenyl)tropane (Iometopane)IBA 08/2006 - 07/2005
2	Pramipexole (Mirapex)FDA LinkGeneric 08/2006 - 01/2006
2	Olanzapine (Zyprexa)FDA Link 01/2006 - 03/2004
2	Mirtazapine (Rexer)FDA LinkGeneric 01/2006 - 03/2004
2	Neuroprotective AgentsIBA 02/2005 - 10/2004
1	COVID-19 VaccinesIBA 03/2023
1	ATH434IBA 11/2021
1	nabilone (Cesamet)FDA Link 10/2020
1	SaltsIBA 01/2020
1	ChemokinesIBA 01/2020
1	CannabidiolIBA 01/2020
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2019
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2019
1	SodiumIBA 01/2019
1	AntibodiesIBA 01/2018
1	Macrophage Colony-Stimulating FactorIBA 01/2018
1	monophosphoryl lipid AIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2016
1	LipidsIBA 01/2016

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2002
3	Transplantation 09/2009 - 12/2005
2	Deep Brain Stimulation 05/2024 - 10/2020
2	Drug Therapy (Chemotherapy) 01/2022 - 10/2019
1	Gastrostomy 01/2021
1	Institutionalization (Institutionalized Persons) 10/2020
1	Tracheostomy 10/2019
1	Continuous Positive Airway Pressure 10/2019
1	Immunotherapy 01/2018